Translational Lung Cancer Research

Papers
(The H4-Index of Translational Lung Cancer Research is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Contrast-enhanced CT and PET-CT characteristics of primary tracheal lymphoepithelioma-like carcinoma: case series58
Pushing the boundaries of minimally invasive surgery56
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review56
Tackling the challenge of brain involvement in driver-negative non-small cell lung cancer49
Metachronous development of L858R and T790M EGFR mutations following ALK inhibitor therapy in stage IV lung adenocarcinoma: a case report47
PFKP confers chemoresistance by upregulating ABCC2 transporter in non-small cell lung cancer45
Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors44
Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review39
Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab38
How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review34
Microbiota modulate lung squamous cell carcinoma lymph node metastasis through microbiota-geneset correlation network33
End-to-side anastomosis in complex tracheal resection and reconstruction: a case series study32
Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer32
Long-term survival after combination therapy with atezolizumab in a patient with small-cell lung cancer: a case report29
The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–203028
Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy28
Real-time digital polymerase chain reaction (PCR) as a novel technology improves limit of detection for rare allele assays27
Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study27
Menstrual factors, reproductive history, and risk of lung cancer: a multi-center population-based cohort study in Chinese females27
Predictive value of perioperative carcinoembryonic antigen changes for recurrence in non-small cell lung cancer25
Discrepancies in PD-L1 expression, lymphocyte infiltration, and tumor mutational burden in non-small cell lung cancer and matched brain metastases25
Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer25
Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?25
Development of an AI model for predicting hypoxia status and prognosis in non-small cell lung cancer using multi-modal data24
Can circulating tumor DNA guide treatment de-escalation in metastatic lung adenocarcinoma harboring actionable genomic alterations?24
0.67484998703003